VYNE Therapeutics Inc. (VYNE) Q3 2020 Earnings Call

Investor webinar replay

Replay transcript excerpt

to the Vine Therapeutics Third Quarter 2020 Earnings Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Michael Wood, LifeSci Advisors. Please go ahead, sir. Thank you. Good morning, everyone, and thank you for joining us this morning. Before we begin the formal remarks, let me remind you that some of the information in the press release that was issued by the company this morning and on this conference call contain forward-looking statements that involve risks, uncertainties, and assumptions. that are difficult to predict. Words that express and reflect optimism, satisfaction with current progress, prospects and projections, as well as words such as believe, intend, expect, plan, anticipate, and similar variations identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not a guarantee of performance, and the company's actual results could differ materially from those contained in such statements. Several factors that could cause or contribute to such differences include are described in detail in the company's filings with the SEC. These forward-looking statements speak only as of today to today's press release and conference call, and the company undertakes no obligation to publicly update any forward-looking statements or supply new information regarding the circumstances after the date of this call. In addition, the financial portion of the call will include certain non-GAAP financial information. The company has provided a reconciliation for such numbers in the earnings release. Participating in this morning's call are Dave Domzalski, Chief Executive Officer of Vine Therapeutics, Andrew Sake, Chief Financial Officer, an...